CrushSCI.com
提供学术论文选刊润色服务
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 期刊封面 医学
返回期刊列表

Review Cycle Records

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Wiley SCIE 非OA
2026新锐 3区2025中科院 4区2025 JCR Q2
136.6平均天数
105.5中位天数
71最短天数
352最长天数
1962025发文量

Paper Review Records

全部论文审稿周期

20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

91 天

Sex‐Specific Relationships Between Nociceptin/Orphanin FQ Peptide (NOP) Receptors and Alcohol Drinking: Longitudinal PET Studies in Cynomolgus Monkeys

作者Paul W. Czoty; Kiran K. Solingapuram Sai; Mack D. Miller; Michael D. Moore; Paul J. Myburgh; Laura R. Grace; Joshua N. Prete; Phillip M. Epperly

作者单位1. Department of Translational Neuroscience Wake Forest University School of Medicine Winston‐Salem North Carolina USA; 2. Department of Radiology Wake Forest University School of Medicine Winston‐Salem North Carolina USA

PDF源文件 DOI 网页
211 天

Use of STOPPFrail Medications Following Receipt of the Danish Terminal Grant: A Nationwide Descriptive Study

作者Daniel Pilsgaard Henriksen; Thomas Øhlenschlæger; Ann‐Cathrine Dalgaard Dunvald

作者单位1. Department of Clinical Pharmacology Odense University Hospital Odense Denmark; 2. Department of Clinical Research University of Southern Denmark Odense Denmark

PDF源文件 DOI 网页
225 天

The History of the Discovery of Vitamin K

作者Hanna Nørgaard Tuxen; Laila Zwisler; Allan Linneberg

作者单位1. Center for Clinical Research and Prevention Copenhagen University Hospital–Bispebjerg and Frederiksberg Copenhagen Denmark; 2. History of Technology DTU Technical University of Denmark Kongens Lyngby Denmark; 3. Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

PDF源文件 DOI 网页
75 天

TRPA1 Regulates Fibrosis‐Associated Transcriptional Pathways in Human Lung Epithelial Cells

作者Leevi Halonen; Samu Luostarinen; Ida Valjus; Julia Vistbacka; Antti Pemmari; Eeva Moilanen

作者单位1. The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University; and Tampere University Hospital, Wellbeing Services County of Pirkanmaa Tampere Finland

PDF源文件 DOI 网页
71 天

Technology‐Driven Decision Support for Opioid Tapering: A Scoping Review

作者Laurits Valberg Hemmingsen; Lærke Karner Overgaard; Uffe Kock Wiil; Daniel Pilsgaard Henriksen

作者单位1. SDU Health Informatics and Technology, The Maersk Mc‐Kinney Moller Institute University of Southern Denmark Odense Denmark; 2. Department of Clinical Pharmacology Odense University Hospital Odense Denmark; 3. Department of Clinical Research University of Southern Denmark Odense Denmark

PDF源文件 DOI 网页
177 天

Deprescription of Psychotropics in Children and Adolescents: Systematic Review of Guidelines and Development of a Deprescribing Algorithm

作者Paul‐Benoît Fargier; Mark Horowitz; Rodolphe Charles; Valérie Rousselon; Erik Fakra; Marie‐Noëlle Beyens; Marie‐Laure Laroche

作者单位1. Pharmacovigilance Centre Saint‐Étienne University Hospital Saint‐Étienne France; 2. Inserm Clinical Investigation Center (CIC‐EC 1408), North Hospital, Saint‐Étienne University Hospital Saint‐Étienne France; 3. Research and Development Department North East London NHS Foundation Trust Ilford UK; 4. Jacques‐Lisfranc Faculty of Medicine, Department of General Practice, Health and Innovation Campus Jean Monnet University Saint‐Priest‐en‐Jarez France; 5. Department of Child and Adolescent Psychopathology, Loire Autism Assessment Unit Saint‐Étienne University Hospital Saint‐Étienne France; 6. Department of Psychiatry Saint‐Étienne University Hospital Saint‐Étienne France; 7. Claude Bernard University Lyon 1, CNRS, INSERM, Lyon Neuroscience Research Center (CRNL), U1028 UMR 5292, PSYR2 Bron France; 8. Centre of Pharmacovigilance and Pharmacoepidemiology Pharmacology, Toxicology and Pharmacovigilance Unit Limoges University Hospital Limoges France; 9. UR 24134 (VieSante), IFR OMEGA HEALTH, Limoges University Limoges France

PDF源文件 DOI 网页
107 天

Future Clinical Pharmacological Decision Support

作者Jan Schjøtt; Leonora Onarheim Bergsjø; Ylva Böttiger

作者单位1. Department of Heart Disease Haukeland University Hospital Bergen Norway; 2. The Department of Natural Sciences, Practical‐Aesthetic, Social and Religious Studies Østfold University College Halden Norway; 3. Department of Health and Nursing Science University of Agder Kristiansand Norway; 4. Department of Biomedical and Clinical Sciences, Division of Clinical Chemistry and Pharmacology Linköping University Linköping Sweden; 5. Department of Clinical Pharmacology, Region Östergötland Sweden

PDF源文件 DOI 网页
190 天

Investigation of the Effects of Perfluorooctane Sulfonic Acid (PFOS) and Perfluorooctanoic Acid (PFOA) Exposure on Interleukin‐17 Signalling and Poly(I:C)‐Induced Lung Inflammation in BALB/c Mice

作者Eda Nur İnkaya; Seçil Karahisar Turan; Nurhayat Barlas

作者单位1. Hacettepe University Department of Biology, Faculty of Science Ankara Turkey

PDF源文件 DOI 网页
104 天

Chemokines in Alzheimer's Disease: Early Defence, Late Damage and the Impact of Sex and Infection

作者Blanca I. Aldana; Kristine Freude

作者单位1. Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences University of Copenhagen Frederiksberg Denmark

PDF源文件 DOI 网页
88 天

A Scoping Review of Dehydrozingerone in Preclinical Pharmacology: Activities, Dose Ranges and Toxicity

作者Mikee C. Mercado; Norazrina Azmi; Mazlina Mohd Said; Juriyati Jalil; Jamia Azdina Jamal; Nor Syafinaz Yaakob

作者单位1. Centre for Drug and Herbal Development, Faculty of Pharmacy The National University of Malaysia Kuala Lumpur Malaysia; 2. Department of Pharmacy, College of Pharmacy and Medical Technology University of San Agustin Iloilo City Philippines

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。